Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
about
Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatmentsLiver Cirrhosis: Evaluation, Nutritional Status, and Prognosis.Role of stereotactic body radiation therapy for hepatocellular carcinomaManagement of hepatocellular carcinoma with portal vein thrombosisCurrent systemic treatment of hepatocellular carcinoma: A review of the literatureControversies and evidence of hepatic resection for hepatocellular carcinomaType I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinomaHepatocellular carcinoma: A comprehensive reviewReduction in non-protein respiratory quotient is related to overall survival after hepatocellular carcinoma treatmentIdentifying prognostic features by bottom-up approach and correlating to drug repositioningDevelopment and Validation of a New Prognostic System for Patients with Hepatocellular CarcinomaComparison of hepatocellular carcinoma in Eastern versus Western populations.Current imaging strategies of primary and secondary neoplasms of the liverEarly and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study.Feasibility of sorafenib combined with local radiotherapy in advanced hepatocellular carcinomaTumor stage and primary treatment of hepatocellular carcinoma at a large tertiary hospital in China: A real-world study.Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma PropertiesA new Child-Turcotte-Pugh class 0 for patients with hepatocellular carcinoma: determinants, prognostic impact and ability to improve the current staging systemsSixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma.Twenty-four hour intra-arterial infusion of 5-fluorouracil, cisplatin, and leucovorin is more effective than 6-hour infusion for advanced hepatocellular carcinoma.Prognostic Impact of Indocyanine Green Plasma Disappearance Rate in Hepatocellular Carcinoma Patients after Radiofrequency Ablation: A Prognostic Nomogram Study.Systemic treatment of hepatocellular carcinoma: Past, present and futurePrognosis following transcatheter arterial embolization for 121 patients with unresectable hepatocellular carcinoma with or without a history of treatmentStaging systems for predicting survival of patients with hepatocellular carcinoma after surgeryUpregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.International validation of the Chinese university prognostic index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong studyMulticenter validation study of a prognostic index for portal vein tumor thrombosis in hepatocellular carcinoma.Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort.V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials.Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.An accurate prognostic staging system for hepatocellular carcinoma patients after curative hepatectomy.Comparison of staging systems of hepatocellular carcinomaComparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort.The role of radiotherapy in the treatment of hepatocellular carcinoma with portal vein tumor thrombus.Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma.Hyponatremia in hepatocellular carcinoma complicating with cirrhosis.Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinomaPrognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.Intermediate hepatocellular carcinoma: How to choose the best treatment modality?
P2860
Q26743666-D8C45D95-CD37-4E74-B476-113F2E79C92FQ26780309-0A6E1F02-1DF7-4A65-BF86-B825355B47F4Q26864969-5CE4C765-5678-45CC-8262-E14156E79A9EQ26996578-B68EDB68-5C85-438F-8FE1-17800F2C2731Q27026036-4506668E-9C0F-425F-B2B0-CFAF1280BE6BQ28072742-E82E8D59-5F18-43D1-BB41-BCF5E851C3EBQ28080514-65FA12D2-4EAC-473B-B08C-AB39FB8D0AB6Q28087638-7F550B37-F926-4135-818C-16D5B08721DFQ28487832-02615A04-39A1-4923-9FAB-888183967D33Q28543844-F7796060-7F87-4783-8B30-0A2EB9B0CD33Q28551586-A2A68CFA-B8E2-41D9-9601-EC3AD00D4B15Q30245396-1C6084BD-941E-41E2-9417-66167ABC632DQ30477021-0F4E500D-1B65-42E4-8A57-E31B768E5E3BQ33403106-93B4069D-3C3F-4944-934D-A94A9E55474FQ33409555-9639C607-9CAB-4F38-8A8D-7A8D8E99B7C8Q33566921-54449ADB-29DB-4855-84F8-0A09B586D587Q33715750-A919AF2F-B10F-45A6-99D2-A90E2B75F84BQ33721747-BF1CB728-B73F-4C66-8C34-939888E84872Q33766930-AF9D4FDA-5DD2-4EC6-B697-76C7B4E5BDD1Q33787850-D1D477BE-8435-41E0-9C5F-2934E069E13AQ33818674-D7664E48-7057-419A-A8BE-C65F1E153A96Q33854034-2A6662A0-DEFA-4E92-86EF-34E582B0B13DQ33867307-B9C5D7B6-A150-4323-B56D-DB10FB640E8BQ34284798-4936069E-0AFC-4F8A-AAA4-EE7C6434AD17Q34344956-C87D95A7-EC50-403E-A426-A36DD26136DFQ34346779-F38FF6CA-792C-4961-AB35-AF9FF4887712Q34386046-8237A020-A783-499F-A05C-A59A4D538B39Q34446810-65652E75-6A2C-4F70-A895-E05BD2FCAC52Q34733478-2B619B4C-A255-4EFC-B3CC-6C4AE981461EQ34827366-5DEC3CFE-ABCC-4DF9-8050-5533252C5F87Q35073362-1940346F-4F70-46A7-AB11-CDF9E1472A3BQ35094309-9AEB5E08-F2D8-44D3-88EC-6ECA8B5D94F1Q35113002-ACDE37C1-709A-40F3-870F-A6BF54CA9ECDQ35114970-F201E33C-DA59-45DF-8EEA-CF44EDB37DC8Q35234037-0114BC71-1C72-422A-B0E2-BE5ACE8582B1Q35289603-F1CFDCC8-448A-4F5C-9514-13E7C4B53DDEQ35349239-50560749-CAD5-4DCA-9315-3FDAF0440A44Q35473069-D416AEA6-FC1C-40DF-A6E2-390D0786CF3CQ35534064-A4BB10F1-BDFB-4579-BA63-EE9FC844C13DQ35626764-A147FE26-2200-4A41-93DC-D8843A70204C
P2860
Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Prognostic staging system for ...... ted Staging Score (JIS score).
@ast
Prognostic staging system for ...... ted Staging Score (JIS score).
@en
type
label
Prognostic staging system for ...... ted Staging Score (JIS score).
@ast
Prognostic staging system for ...... ted Staging Score (JIS score).
@en
prefLabel
Prognostic staging system for ...... ted Staging Score (JIS score).
@ast
Prognostic staging system for ...... ted Staging Score (JIS score).
@en
P356
P1476
Prognostic staging system for ...... ted Staging Score (JIS score).
@en
P2093
Hobyung Chung
Yukio Osaki
P304
P356
10.1007/S005350300038
P577
2003-01-01T00:00:00Z